What is CNS Lymphoma and How is it Treated?

Medically reviewed by David Reardon, MD Central nervous system (CNS) lymphoma is an extremely rare form of non-Hodgkin lymphoma that involves the brain and spinal cord, the primary components of your body’s central nervous system. Non-Hodgkin lymphoma is a type of cancer that originates in lymphocytes, infection-fighting white blood cells that make up your immune … Read more

Inoperable Cancer: What Does it Mean?

A cancer can be inoperable for a variety of reasons. “Liquid cancers,” such as leukemia, lymphoma, and multiple myeloma, are considered inoperable by nature, because they involve cells or tissues that are dispersed throughout the body. Leukemia and multiple myeloma, for example, originate in abnormal cells of the bone marrow, the spongy material within the … Read more

What is CRISPR and How Can It Help Cancer Research?

CRISPR, a powerful new tool for editing the DNA instruction manual in animals and humans, is proving a boon to cancer research. Scientists say CRISPR has dramatically accelerated the process of making animal models of cancer and is speeding the search for new molecular targets for cancer drugs. The technique is also being used in … Read more

MATCHing Precision Medicine to All Kids With Cancer

This originally appeared on Vector, Boston Children’s Hospital’s blog. A multi-center clinical trial is now offering nationwide genetic profiling services to pediatric and young adult cancer patients across the U.S. The goal is to identify gene mutations that can be individually matched with targeted drugs. “This is the first-ever nationwide precision medicine clinical trial for … Read more

Patrice Kelly’s Journey from Jimmy Fund Clinic Mom to Breast Cancer Patient

Charlotte Kelly hated having her chemotherapy port accessed, but her mother, Patrice, found a way to calm the toddler. Each time tears came, Patrice would rub her nose against Charlotte’s – and the pair would get past their fears together. Today the ritual continues, even though Charlotte’s last neuroblastoma checkup at Dana-Farber/Boston Children’s Cancer and … Read more

One Family, One Researcher: How Mikey’s Journey is Fueling an Attack on DIPG

This story first appeared on Vector, a blog of Boston Children’s Hospital. “It’s a brutal disease; there’s just no other way to describe DIPG,” says Steve Czech. “And what’s crazy is that there aren’t many treatment options because it’s such a rare, orphan disease.” Czech’s son, Mikey, was diagnosed with a diffuse intrinsic pontine glioma … Read more

Breast Cancer Treatment: What’s the Latest?

Not only are more effective drugs for breast cancer coming to the clinic, but oncologists are making important progress in matching breast cancer treatment to specific patients and the molecular characteristics of their tumors. It’s also becoming more feasible to rachet the intensity of treatment up or down depending on the patient’s risk status, and … Read more

Young Neuroblastoma Patient and Family Make New Home at Dana-Farber/Boston Children’s

Bridgette West sparkled last fall in the “Fight Song” music video created by patients at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. But before the 2-year-old became a social media standout with her dancing, she and her family faced challenges that went far beyond a cancer diagnosis. In the summer of 2015, after struggling for … Read more

How Genetics Can Help Predict — and Sometimes Stop — Childhood Cancers

Amy Kindstedt hates cancer, but the 9-year-old is very thankful for one thing: Because genetic testing on her baby brother Hunter revealed he had the same genetic mutation she did, his cancer was caught much earlier –  possibly sparing him the same level of intense treatment she endured. The mapping of the human genome has … Read more

How Can We Make Personalized Therapy for Childhood Cancer a Reality?

This blog post originally appeared on Vector, Boston Children’s Hospital’s science and clinical innovation blog. By Tom Ulrich For some pediatric cancers, such as acute lymphoblastic leukemia, older forms of therapy — and older ways of defining who receives which therapy — have served well over the last few decades. But that approach is no longer … Read more